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Abstract: Swine production workers are exposed simultaneously to multiple contaminants.
Occupational exposure to aflatoxin B1 (AFB1) in Portuguese swine production farms has already
been reported. However, besides AFB1, data regarding fungal contamination showed that exposure
to other mycotoxins could be expected in this setting. The present study aimed to characterize the
occupational exposure to multiple mycotoxins of swine production workers. To provide a broad
view on the burden of contamination by mycotoxins and the workers’ exposure, biological (urine)
samples from workers (n = 25) and 38 environmental samples (air samples, n = 23; litter samples,
n = 5; feed samples, n = 10) were collected. The mycotoxins biomarkers detected in the urine samples
of the workers group were the deoxynivalenol-glucuronic acid conjugate (60%), aflatoxin M1 (16%),
enniatin B (4%), citrinin (8%), dihydrocitrinone (12%) and ochratoxin A (80%). Results of the control
group followed the same pattern, but in general with a lower number of quantifiable results (<LOQ).
Besides air samples, all the other environmental samples collected presented high and diverse
contamination, and deoxynivalenol (DON), like in the biomonitoring results, was the most prominent
mycotoxin. The results demonstrate that the occupational environment is adding and contributing to
the workers’ total exposure to mycotoxins, particularly in the case of DON. This was confirmed by
the biomonitoring data and the high contamination found in feed and litter samples. Furthermore,
he followed multi-biomarker approach allowed to conclude that workers and general population
are exposed to several mycotoxins simultaneously. Moreover, occupational exposure is probably
described as being intermittent and with very high concentrations for short durations. This should
be reflected in the risk assessment process.
Keywords: mycotoxins; occupational exposure; swine production; biomonitoring;
mycotoxins mixture
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Key Contribution: This study allowed to conclude that the workplace environment adds significantly
to the mycotoxins exposure resulting from ingestion of contaminated food, and to recognize that
inhalation is an important exposure route. Moreover, the findings showed us that workers and
controls are exposed to several mycotoxins simultaneously. All these findings were possible due to
the environmental and biological monitoring approaches.
1. Introduction
The confinement buildings used for swine production are recognized for their high levels of
contamination with fungi and their metabolites [1–6]. Previous studies performed in swine farms
demonstrated that this environment could be considered an occupational setting with high levels of
exposure to dust aerosolization [4,7–9], and consequently it results in the widespread presence of fungi
and their metabolites, such as volatile organic compounds and mycotoxins [1,2,4,9–11]. Therefore,
it is expected that swine production workers are exposed simultaneously to multiple contaminants,
as demonstrated previously by some authors [5,8]. Besides, the swine feed contamination by
mycotoxins is also a well-known and frequently reported issue in Portugal [12] and all over the
world [13–16].
Occupational exposure to aflatoxin B1 (AFB1) in Portuguese swine production farms has been
reported [17]. However, data regarding fungal contamination showed that exposure to other
mycotoxins besides AFB1 could be expected in this setting. Indeed, in addition to the Aspergillus
section Flavi, other fungal species recognized as mycotoxin producers were found in this occupational
environment [5,10]. The most prevalent found in air (20.9%) and surface (26.6%) samples was the
Aspergillus section Versicolores. However, other Aspergillus sections were also found, namely Nigri,
Circumdati and Fumigati [5,10], and all of them have recognized toxigenic potential [18], besides the
clinical relevance of Fumigati section [19].
Occupational exposure to mycotoxins is considered a complex process since it is associated with
co-exposure to several mycotoxins by different exposure routes. In this context, human biomonitoring
is of particular importance, characterizing the workers exposure to multiple mycotoxins and taking
advantage of already available analytical methods that cover the detection and quantification
of several mycotoxins and metabolites simultaneously in different biological samples [20–23].
Therefore, biomonitoring has an important role in the determination of the real human exposure
to mycotoxins [17,20,22,24–27]. Biomonitoring covers not only mycotoxin intake from all dietary
sources, but also exposure by other routes, such as inhalation of mycotoxins at the workplace [28].
Nowadays, the use of biomarkers has become more common, and research to discover new and more
specific biomarkers has been proposed since the use of biomarkers is proven to be a successful method
to assess exposure to xenobiotics. However, some challenges have to be addressed, such as the deep
knowledge about the toxicokinetics and the possible metabolites for all relevant mycotoxins [29].
Other challenges include the frequent discovery of new metabolites for a specific mycotoxin and
the need for understanding their possible use for biomonitoring studies, considering the measuring
feasibility and the representativeness of the information regarding exposure to that mycotoxin [30].
Few studies have been performed with the use of biomarkers to study occupational exposure to
mycotoxins [23,27,28].
Whether workplace-related exposure could represent a significant exposure source to mycotoxins
as compared to exposure through ingestion of contaminated food constitutes a critical issue.
As suggested by Reference [28], the comparison of results from workers and from non-occupationally
exposed individuals (controls) should shed light on this issue contributing to the clarification of the
importance of some occupational settings to multiple mycotoxins exposure in humans. The control
group includes workers from administrative companies from the same locality and where the
workplace environment does not have conditions to promote exposure to mycotoxins. This enables us
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to take into account the exposure by food intake and to have a better understanding of the role of the
working environment in the total burden of mycotoxin exposure [4,24].
The present study aims to characterize the occupational exposure to multiple mycotoxins,
including aflatoxin M1 (AFM1), aflatoxin B1 (AFB1), aflatoxin B2 (AFB2), aflatoxin G1 (AFG1), aflatoxin
G2 (AFG2), patulin (PAT), nivalenol (NIV), deoxynivalenol (DON), deoxynivalenol-3-glucoside
(DON-3-G), 15-acetyldeoxynivalenol (15-AcDON), 3-acetyldeoxynivalenol (3-AcDON),
deepoxy-deoxynivalenol (DOM-1), deoxynivalenol-glucuronide (DON-GlcA), fusarenon-X (FUS-X),
α-zearalanol (α-ZAL), β-zearalanol (β-ZAL), α-zearalenol (α-ZEL), β-zearalenol (β-ZEL), zearalenone
(ZAN), zearalenone (ZEN), toxin T-2 (T-2), toxin HT-2 (HT-2), toxin HT-2-4-glucuronide (HT-2-4-GlcA),
T-2 tetraol, T-2 triol, neosolaniol (NEO), monoacetoxyscirpenol (MAS), diacetoxyscirpenol (DAS),
fumonisin B1 (FB1), fumonisin B2 (FB2), fumonisin B3 (FB3), roquefortine C (ROQ-C), griseofulvin
(GRIS), ochratoxin A (OTA), ochratoxin B (OTB), ochratoxin alpha (OTα), mycophenolic acid (MPA),
mevinolin (MEV), sterigmatocystin (STER), citrinin (CIT), dihydrocitrinone (DH-CIT), Enniatin B
(EnB), of workers of swine production, in addition to the previously documented exposure to AFB1.
2. Results
2.1. Biomonitoring
2.1.1. Participant Characteristics
The workers group of this study was composed of employees of five swine production farms.
The volunteers of the “control group” were working in offices without expected occupational exposure
to mycotoxins. The mean ages in control participants (n = 19) were similar to those of the workers
(n = 25). For the control group, the median age was 40 years with a range of 32–54 years. The swine
workers had a median age of 38.6 years with a range of 21–62 years (Table 1).
Table 1. Participants age and years of activity.
Groups Female Male Age (Median; IQR) Years of Activity (Median; IQR)
Workers (n = 25) 13 12 38.6; 30.0–46.0 3.5 ± 10.1
Controls (n = 19) 7 12 40.0; 38.5–44.0 -
IQR = Interquartile range.
2.1.2. Mycotoxins and Their Metabolites in Urine Samples
A summary of the biomonitoring data is presented in Tables 2 and 3. Samples with mycotoxins
biomarkers above the respective Limit of Detection (LOD) were considered positive. The mycotoxins
biomarkers detected in the urine samples of workers group were DON-GlcA (60%), AFM1 (16%),
EnB (4%), CIT (8%), DH-CIT (12%), and OTA (80%). Results for participants of the control group
followed the same pattern, but in general with a lower number of positive samples (>LOD).
Here, DON 3 Glc was used as a reference that was chromatographically not separated from DON
15 GlcA, because both analytes are co-eluting in the used instrument set up. Consequently, the signal
was accepted as the sum of both analytes [21,22]. As already reported in Reference [30], it is possible to
separate the DON-3-GlcA, and DON-15-GlcA. However, in the instrument set-up, this would extend
the liquid chromatography run up to 17 min. By doing so, the peak shapes of later eluting peaks would
be worse off. It was not the aim of this study to distinguish between them, but to incorporate an early
eluting polar metabolite.
Considering the values higher than LOD, DON-GlcA and OTA were the most prevalent
biomarkers in the analyzed urine of the workers group, being 60% and 80% respectively. Data presented
in Tables 2 and 3 showed that glucuronidation is a metabolic pathway for DON excretion since it was
detected in samples from both workers and control groups.
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Table 2. Mycotoxins biomarkers detected in urine samples from workers and controls.
Groups DON-GlcA AFM1 EnB CIT DH-CIT OTA
LOD (µg/L) 1.24 0.11 0.006 0.61 0.115 0.011
LOQ (µg/L) 4.14 0.38 0.020 2.00 0.383 0.036
Workers (n = 25)
>LOQ (n, %) 13, 52% 4, 16% - 1, 4% 1, 4% 1, 4%
LOD–LOQ (n, %) 2, 8% - 1, 4% 1, 4% 2, 8% 19, 76%
<LOD (n, %) 10, 40% 21, 84% 24, 96% 23, 92% 22, 88% 5, 20%
Controls (n = 19)
>LOQ (n, %) - - - 1, 5% - -
LOD–LOQ (n, %) 11, 58% 1, 5% 2, 11% 10, 53% 2, 11% 13, 68%
<LOD (n, %) 8, 42% 18, 95% 17, 89% 8, 42% 17, 89% 6, 32%
Limit of Detection (LOD); Limit of Quantification (LOQ); Deoxynivalenol-glucuronide (DON-GlcA); Aflatoxin M1
(AFM1); Enniatin B (EnB); Citrinine (CIT); Dihydrocitrinone (DH-CIT); Ochratoxin A (OTA).
Table 3. Mycotoxins biomarkers levels (>LOQ) in urine samples from workers and controls (µg/L).
Groups DON-GlcA AFM1 CIT DH-CIT OTA
Workers
Range 22.0–71.1 2.1–5.4 - - -
Median 32.8 4.9 - - -
IQR 27.2–44.5 4.5–8.1 - - -
Single value - - 5.3 0.8 0.1
Controls (µg/L)
Single value 24.2
Interquartile range (IQR); Deoxynivalenol-glucuronide (DON-GlcA); Aflatoxin M1 (AFM1); Enniatin B (EnB);
Citrinine (CIT); Dihydrocitrinone (DH-CIT); Ochratoxin A (OTA).
Most of the other mycotoxin biomarkers detected in urine samples followed a similar pattern to
DON, that is, a higher proportion of positive samples (>LOD) in the workers group than in the control
group (Table 4). However, the differences were not as remarkable for DON-GlcA detection. CIT and
DH-CIT were also both detected in these participants, meaning that this compound is a metabolite of
CIT detoxification (Table 4).
Table 4. Differences in the proportion of exposures between the control group and workers group.
Mycotoxins Groups Total Workers Controls p Value
DON-GlcA
Not exposed 18 (40.9%) 10 (40.0%) 8 (42.1%)
1 *Exposed 26 (59.1%) 15 (60.0%) 11 (57.9%)
AFM1
Not exposed 39 (88.6%) 21 (84.0%) 18 (94.7%)
0.370 **Exposed 5 (11.4%) 4 (16.0%) 1 (5.3%)
CIT
Not exposed 31 (70.5%) 23 (92.0%) 8 (42.1%)
0.001 *Exposed 13 (29.5%) 2 (8.0%) 11 (57.9%)
DH-CIT
Not exposed 39 (88.6%) 22 (88.0%) 17 (89.5%)
1 **Exposed 5 (11.4%) 3 (12.0%) 2 (10.5%)
EnB
Not exposed 41 (93.2%) 24 (96.0%) 17 (89.5%)
0.57 **Exposed 3 (6.8%) 1 (4.0%) 2 (10.5%)
OTA
Not exposed 11 (25.0%) 5 (20.0%) 6 (31.6%)
0.598 *Exposed 33 (75%) 20 (80.0%) 13 (68.4%)
* Chi-Square Test of Independence; ** Fisher Exact Test.
Regarding co-exposure to several mycotoxins, there are three workers that presented exposure to
three mycotoxins/metabolites simultaneously: 2 workers with the combination of DON-GlcA, AFM1,
and OTA, and 1 worker with the combination of AFM1, CIT, and OTA. However, the most common
situation was the presence of the DON metabolite and OTA (8 workers). Regarding controls, most of
the individuals showed exposure to two mycotoxins (42%) which was also the most common situation
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observed—the co-exposure to DON (through DON-GlcA measurement) and OTA (3 individuals).
There were also 3 (21%) individuals with exposure to a mixture of 4 mycotoxins and another 3
individuals (21%) with simultaneous exposure to 3 mycotoxins.
In total, 18 (75%) workers and 15 (78%) individuals from the control group showed exposure to
more than 1 mycotoxin.
2.2. Environmental Samples
All the collected environmental samples (air, liter, and feed) were analyzed for the presence of
thirty-six mycotoxins and their metabolites (Tables 5 and 6).
Table 5. Mycotoxins present in environmental samples.
Farms
Environmental
Samples
Mycotoxins *
Number of Mycotoxins
(>LOD) LOD–LOQ > LOQ
Farm A
Feed—Sample 1
NIV, DON-3-G, DON, ZEN, NEO,
15-AcDON, 3-Ac-DON, MAS,
DAS, FB1, FB2, FB3, GRI, T-2,
HT-2, MPA, STER
17 2 15
Feed—Sample 2
DON, ZEN, 15-AcDON,
3-AcDON, FB1, FB2, FB3, T-2,
HT-2, MPA, MEV
11 0 11
Air
Litter DON, ZEN, FB1, STER 4 0 4
Farm B
Feed—Sample 1
DON-3-G, DON, ZEN,
15-AcDON, FB1, FB2, FB3, T-2,
HT-2, OTA, MPA, MEV
12 1 11
Feed – Sample 2
DON-3-G, DON, ZEN,
15-AcDON, 3-AcDON, MAS, FB1,
FB2, FB3, T-2, HT-2, MPA
12 3 9
Air
Litter DON, ZEN, GRI, STER 4 0 4
Farm C
Feed—Sample 1
DON, ZEN, NEO, 15-AcDON,
FB1, FB2, FB3, GRI, T-2, HT-2,
MPA
11 0 11
Feed—Sample 2
DON-3-G, DON, ZEN,
15-AcDON, FB1, FB2, FB3,
T-2,HT-2, MPA, MEV
11 3 8
Air
Litter DON, ZEN, DOM-1, STER 4 0 4
Farm D
Feed—Sample 1
DON-3-G, DON, ZEN,
15-AcDON, FB1, FB2, FB3, T-2,
HT-2, MPA, MEV
11 1 10
Feed—Sample 2 DON, ZEN, 15-AcDON, FB1, FB2,FB3, T-2, HT-2, MPA
9 1 8
Air
Litter DON, ZEN, FB1, GRI, STER 5 0 5
Farm E
Feed—Sample 1
DON-3-G, DON, ZEN, NEO,
15-AcDON, FB1, FB2, FB3, T-2,
HT-2, MPA
11 1 10
Feed—Sample 2 DON, ZEN, 15-AcDON, FB1, FB2,T-2, HT-2, MPA, STER 9 1 8
Air
Litter DON, GRI, STER, MPA 4 0 4
* Mycotoxins with values >LOD; nivalenol (NIV), deoxynivalenol (DON), deoxynivalenol-3-glucoside
(DON-3-G), fusarenon-X (FUS-X), α-zearalanol (α-ZAL), β-zearalanol (β-ZAL), β-zearalenol (β-ZEL), α-zearalanol
(α-ZEL), zearalenone (ZAN), zearalenone (ZEN), Toxin T2 (T-2), Toxin HT2 (HT-2), deepoxy-deoxynivalenol
(DOM-1), neosolaniol (NEO), 15-acetyldeoxynivalenol (15-AcDON), 3-acetyldeoxynivalenol (3-AcDON),
monoacetoxyscirpenol (MAS), diacetoxyscirpenol (DAS), fumonisin B1 (FB1), fumonisin B2 (FB2), fumonisin B3
(FB3), roquefortine C (ROQ-C), griseofulvin (GRI), ochratoxin A (OTA), ochratoxin B (OTB), mycophenolic acid
(MPA), mevinolin (MEV), sterigmatocystin (STER).
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Table 6. The concentration of mycotoxins quantified in the feed (ng/g).
Mycotoxins Range of Values/Mean
NIV <LOQ
DON-3-G <LOQ
DON 137–388/272
ZEN 6.83–32.35/14.4
NEO 0.96–12.4/4.84
15-AcDON 6.94–35.64/14.79
3-Ac-DON 4.48–10.9/7.66
MAS <LOQ–0.70
DAS 1.18
FB1 6.52–366/149
FB2 2.06–97.6/48.3
FB3 6.36–61.2/19.6
GRIS 1.59–1.88/1.74
T-2 <LOQ–24.6/3.81
HT-2 <LOQ–28.1/3.84
MPA 0.80–89.0/29.7
STER <LOQ–0.72
MEV 0.43–0.62/0.55
OTA 0.30
Nivalenol (NIV), deoxynivalenol (DON), deoxynivalenol-3-glucoside (DON-3-G), fusarenon-X (FUS-X), α-zearalanol
(α-ZAL), β-zearalanol (β-ZAL), β-zearalenol (β-ZEL), α-zearalanol (α-ZEL), zearalenone (ZAN), zearalenone (ZEN),
Toxin T2 (T-2), Toxin HT2 (HT-2), deepoxy-deoxynivalenol (DOM-1), neosolaniol (NEO), 15-acetyldeoxynivalenol
(15-AcDON), 3-acetyldeoxynivalenol (3-AcDON), monoacetoxyscirpenol (MAS), diacetoxyscirpenol (DAS),
fumonisin B1 (FB1), fumonisin B2 (FB2), fumonisin B3 (FB3), roquefortine C (ROQ-C), griseofulvin (GRIS), ochratoxin
A (OTA), ochratoxin B (OTB), mycophenolic acid (MPA), mevinolin (MEV), sterigmatocystin (STER).
Regarding the air samples, only three samples from two different farms showed contamination
by sterigmatocystin (STER) (<LOQ–1.42 ng/g). All the other air samples were found to be negative for
the analyzed mycotoxins and metabolites. Regarding the litter samples, it was observed that the most
prevalent mycotoxins were DON (<LOQ–76.4 ng/g) and STER (1.14–2.69 ng/g) which were detected in
all litter samples and in considerably higher amounts than the other analyzed mycotoxins. Zearalenone
was a mycotoxin that was also detected in 4 out of 5 farms, but in lower amounts (<LOQ–0.78 ng/g).
Concerning the feed samples, it is possible to observe that the common scenario is the
co-occurrence of mycotoxins in the same sample (9–17 mycotoxins were detected in the same
sample). The higher values were obtained for DON (values between 137–388 ng/g) and fumonisins,
particularly FB1 (values between 6–366 ng/g). Others mycotoxins, such as ZEN, 3-AcDON, 15-AcDON,
and DON-3-G, fumonisins (FB1, FB2 and FB3), and type A trichothecenes such as T-2 and HT-2, were
also detected in almost all the feed samples.
3. Discussion
This study is the result of previous work related to occupational exposure to mycotoxins and the
need to identify the contribution of specific occupational settings to total mycotoxins exposure. At the
same time, this study and previous ones [27,31] allow us to recognize mycotoxins as real and common
occupational risk factors in specific occupational settings. Indeed, as in previous reports, results
showed that the occupational environment and probably specific work tasks developed by the workers
implicate exposure to mycotoxins by inhalation. Although no statistical significance was obtained
in some tests, results demonstrated that only workers presented quantifiable levels of DON-GlcA (a
biomarker of exposure to DON), AFM1 (the hydroxylated metabolite of AFB1, EnB (also a Fusarium
toxin)), DH-CIT (the main metabolite of CIT) and OTA (the most-abundant food-contaminating
mycotoxin). One possible reason for the absence of statistical significance in some tests could be due
to the small sample size in both groups. Additionally, the type of urine samples used for this study
(spot samples) might be responsible since 24 h urine (or first-morning void) are more concentrated
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with mycotoxins than one spot urine sample [32]. For instance, in the case of DON, previous studies
showed that there is clear evidence that urinary DON excretion varies at different times of the day,
and spot samples cannot describe these differences [33–35].
Consequently, the results were mainly discussed in the context of their values and not their
statistical significance. However, and despite the small number, results indicate that even if workers
are exposed through food consumption to some of these mycotoxins, occupational exposure is adding
and contributing to the total exposure. This is not difficult to understand if we consider that, besides
air samples, all the other environmental samples collected presented high and diverse levels of
contamination, and DON was, like in the biomonitoring results, the most prominent mycotoxin.
Additionally, the almost null results regarding air samples can be explained by the fact that mycotoxins
are not volatile, and for the workers, exposure by inhalation occurs when exposure to organic dust
happens in specific tasks since dust functions as a mycotoxins carrier and enters respiratory systems.
A previous work developed by Reference [36] identified in swine farms the predictors for dust exposure
being associated with tasks involving intense animal handling, such as castrating, ear tagging, and teeth
cutting, as well as activities related to feeding, floor sweeping, and removal of dry manure. If we
consider the results obtained in the current study concerning the high contamination found in the
litter and feed samples, it is possible to estimate that feeding, floor sweeping, and removal/change of
litter will be responsible for the workers’ dust and mycotoxins exposure. Furthermore, dust particles
containing mycotoxins can be deposited in the skin, leading to dermal absorption, or work surfaces
contaminated with dust particles can also be touched, generating the opportunity for additional skin
contact [4,37]. Consequently, this exposure route is also possible in this occupational setting since
workers do not use gloves and most of the workers were using short leaves when performing their
working tasks. Unfortunately, there is a lack of information on the adsorption rates from lungs and
skin for mycotoxins in humans.
The results obtained regarding feed contamination (between 9–17 mycotoxins in the same sample)
demonstrate that feed has a relevant role in workplace environment contamination with mycotoxins
and the handling of feed is probably one of the tasks that implicates exposure. An important
preventive action will be the choice of the raw materials used during feed formulation, avoiding
the use of materials with high mycotoxin contaminations. Considering this aspect, it seems of interest
to highlight the influence that the geographic origin of the raw material can have on the mycotoxin
contamination of feed at different stages of production [38]. Previously, and similarly to our findings,
DON has been reported as the more prevalent mycotoxin in the different types of raw materials
used to produce feed, since it is common to find DON, for instance, in maize, wheat, soybean meal,
and others [38]. This contamination has several consequences for pig health, such as increased
susceptibility to infectious diseases, reactivation of chronic infection, and a decreased vaccine efficacy,
with a huge economic impact on pig production [39]. Other mycotoxins present in all the feed samples
analyzed, although in lower concentrations, such as ZEN, fumonisins (FB1, FB2, and FB3), and type
A trichothecenes (T-2 and HT-2) are also commonly reported as contaminants of feed and have
several health consequences for the animals [38,39]. Therefore, preventive actions taken to avoid feed
contamination will result in preventing/reducing workers exposure to mycotoxins and, at the same
time, guarantee better production results.
Exposure to mycotoxins mixtures was also once more revealed in this biomonitoring study.
Both group results in workers and controls showed that this is a common aspect. This is understandable
since, besides the presence of multiple mycotoxins in the occupational environment, this is also a
common feature of food commodities. Even the most frequent combination found in biological samples
from workers and controls (DON and OTA) were already reported in several foods from European
countries such as beer, pasta, cereals, and cereal-based foods [26,40].
A previous paper developed by Reference [41] assessed DON and OTA interactions using two
different model systems appropriate for the evaluation of intestinal or liver toxicity and an experimental
design that included realistic doses of each mycotoxin. The authors found that Caco-2 and HepG2
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cells were more sensitive to DON alone than to OTA. Moreover, when combined, OTA-DON showed
the most toxic combinations for Caco-2 and HepG2, respectively, having both synergistic effects at
all inhibition levels [41]. The same trend was found for the combination AFB1-DON, a mixture also
observed in our study. Therefore, the results obtained in the present study, even if exposure route is
mainly via inhalation, suggest that exposure to DON occurs in combination with other mycotoxins
and this should be considered when performing risk assessment.
Regarding the high prevalence of OTA in the samples of both groups, previous studies developed
in the Portuguese population found OTA in biologic fluids [40,42–44] relating to the consumption
of some food commodities. Additionally, Reference [43] concluded that the estimated daily intake
values in the Portuguese populations are higher than other European populations. Indeed, our results
are probably explained once again by the fact that this mycotoxin is one of the most-abundant
food-contaminating mycotoxins [44]. In Portugal, the bread is the major cereal-derived product
consumed, and it is probably the main factor responsible for OTA exposure, also due to the
contamination levels. Other products such as wine and pork also contribute to exposure but are more
related to the high consumption rate of these products and not so much due to their contamination
levels [44].
One aspect relevant to the analysis is the fact that in all environmental samples, including
air samples, STER was detected, with a high frequency and concentration in the feed samples.
STER synthesis is restricted to species in four sections in Aspergillus (Ochraceorosei, Versicolores,
Nidulantes, and Flavi) [45]. However, most of the Aspergillus species from the section Versicolores
are able to produce STER, and this was the most prevalent species on air and surface samples from
the swine farms engaged in this study. Therefore, besides the feed contaminated with STER that has
already been reported [45], it seems that the swine farm environment can promote this mycotoxin
production by the Versicolores section. STER is extensively metabolized essentially by glucuronidation
but the identification of the glucuronide forms in human biological samples has not been accomplished
until now [29]. Further studies should be developed to determine the most suitable STER biomarkers
for identifying exposure.
This study demonstrates once more the usefulness of biomonitoring tools. These tools not
only allowed us to identify that the occupational environment is contributing to the swine workers’
total exposure to mycotoxins but also it revealed that exposure occurs as a mixture of mycotoxins.
Furthermore, and considering that some mycotoxin mixtures could lead to additive or synergistic
effects, a significant threat to human and animal health could occur. However, most studies have
been carried out over less than three days and at concentrations above the legal limits available
in the context of food safety. There is therefore a lack of data about chronic exposure at sub-toxic
mycotoxin concentrations, closer to real food and feed consumption habits [46]. This implies also the
availability of enough sensitive analytical techniques for the quantification of biomarkers of multiple
co-occurring mycotoxins [47]. Likewise, and concerning occupational exposure, probably we are
dealing with intermittent exposures linked with very high concentrations within a short duration
of time. This exposure is in addition to the exposure occurring via food intake (chronic exposure to
low amounts). Subsequently, there is a gap in the knowledge concerning the approach which should
be used to accomplish a suitable risk assessment methodology. Toxicokinetics and toxicodynamics
data from exposure sources other than ingestion, as well as human biomonitoring guidance values,
are needed in order to anticipate the associated risk. This implies that the involved stakeholders need
to extend the dialogue across different chemical sectors (food safety vs. occupational health) in order
to come to more overarching and harmonized approaches [48].
Moreover, the exposure scenario found in this occupational setting can suffer variations due
to climate change that will affect cereals (used for feed), agricultural practices, and the ecological
niches of mycotoxigenic fungi in a particular area. In the future, mycotoxin producers in temperate
climates will be replaced by better-adapted species or mutants which may produce new secondary
metabolites [49,50]. Therefore, monitoring programs considering biological and environmental
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samples should be developed continuously to allow for a better and more detailed exposure scenario.
In addition to this, adequate health surveillance programs should be applied.
4. Conclusions
Despite the small numbers of individuals in both groups (workers and controls), this study
allowed us to recognize that the occupational environment is adding and contributing to the workers’
total exposure to mycotoxins. This was also confirmed by the high contamination found in feed
and litter samples. Additionally, the multi-biomarker approach permitted us also to conclude that
exposure to mycotoxins, in workers and in the general population, is characterized by being a mixture
of mycotoxins, and this should be reflected in risk assessment processes.
5. Materials and Methods
5.1. Setting Characteristics
This study was conducted between June and July 2017 in five Portuguese swine locations in the
Lisbon district and is part of an enlarged exploratory study aiming to characterize occupational
exposure to microorganisms and mycotoxins in this setting (Instituto Politécnico de Lisboa:
IPL/2016/BBIOR_ESTeSL, Date of approval: 7 December 2016). While being part of a larger study
in which additional environmental characterization was carried out, this paper presents the results
regarding environmental samples collected by active (air) and passive (feed and litter) methods in
which mycotoxins assessment was performed. Additionally, biomonitoring was performed involving
the workers who agreed to participate.
Five Portuguese swine farms were selected according to three specific criteria: Location within the
Lisbon district, a high number of animals, and the number of workers. All the farms were divided into
five pavilions dedicated to different phases of animal growth/age, namely pig gestation, maternity,
stalls, pig fattening areas, and quarantine confinement. The five farms had been assessed in a previous
study from our group [17], but no modifications in working activities or safety procedures were
made until this new sampling campaign was performed in the scope of a new study. The floor in the
swine maternities was covered with newspaper. Manure removal systems were present in all farm
facilities, with complete removal from the building several times a day. The ventilation systems in the
studied farm buildings consisted of mechanical ventilation by wall exhaust fans coupled with natural
ventilation through the operation of a winch-curtain. Swine farm workers did not use respiratory
protection devices during tasks performance.
Fungal burden found in the different environmental matrices from the assessed swine was already
reported [5]. Besides the most prevalent (Cladosporium sp. and Penicillium sp.), other fungal species
with recognized toxigenic potential were also identified, namely the Fusarium graminearum complex
on air samples, Fusarium culmorum on feed samples, and Aspergillus section Circumdati on surfaces.
Aspergillus section Circumdati was the most prevalent (55%) on MEA followed by Aspergilli (25%).
Different Aspergillus sections were more prevalent on DG18, Versicolores being the most identified
(50%), followed by Usti (20.8%).
5.2. Sampling
In order to provide a broad view on the burden of contamination by mycotoxins and the workers’
exposure to these toxins, biological (human biomonitoring) samples from workers (n = 25) and
environmental (air, litter, and feed) (n = 38 samples) samples were collected.
5.2.1. Human Biomonitoring Approach
Qualitative and quantitative determinations of mycotoxins with the objective of occupational
exposure assessment at an individual level for each study participant were performed using a
multi-analyte approach since it allows for a more precise and realistic exposure assessment over
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a broad range of different analytes [51,52]. Workers that developed tasks which implicate the handling
of piglets, feed, or litter are normally inside the pavilions and were all invited to participate in this
study. In the end, 25 workers (out of 26) were enrolled in this study.
A control group (not exposed) was also enrolled in the study (n = 19) in order to investigate
mycotoxin background levels for the Portuguese population and to evaluate and easily detect putative
possible differences regarding the exposure of the workers group. Therefore, the control group
was composed of individuals who conducted administrative tasks in an educational institution
without recognized activities known to involve or promote occupational exposure to mycotoxins [4].
Additionally, the building of the educational institution was well maintained, not showing signs of
degradation that can implicate optimal conditions for fungal growth. In this study, it is assumed that
both groups (workers and controls) have similar diets and consequently it was hypothesized that the
main difference of exposure to mycotoxins was work activities. The same control group was used
in another research project [27] since both projects were developed almost simultaneously and the
workers groups are from companies located in the same region of Portugal.
This study was conducted in full accordance with the World Medical Association Declaration of
Helsinki and European Commission recommendations [53,54]. Written consents from the participants
involved in this study were obtained. All participants were informed about the scope and the aim of
this study and signed a consent form. After data collection, all the personal data was anonymized to
avoid identification of the participants. Moreover, all the data was pseudonymized in order to protect
the privacy and minimize the risk in the event of unauthorized access to the participant’s data.
Additionally, during a personal interview, participants answered a questionnaire to collect
personal data such as age, detailed current and previous occupational history, and tasks performed in
the two previous days prior urine collection, as well as activities outside the company, e.g., agriculture
or animal production. However, it only collected data needed to meet the research objectives and
to obtain contextual information to enable a better analysis of the biomonitoring data. In each unit,
workers collected spot urine samples (more or less 25 mL) at the end of the morning (between 11 a.m.
and 1 p.m.) in a dedicated room in each swine farm facility. This schedule was the one indicated by
the companies as the most suitable for samples collection.
5.2.2. Environmental Sampling
Air, litter, and feed from the swine farms (identified as A, B, C, D, and E) were analyzed to
assess mycotoxins contamination. The objective of considering these environmental samples was to
recognize the most relevant contamination source of the occupational environment and to identify
potential preventive measures that could be more adequate to reduce workers exposure to mycotoxins.
In each area of the swine farms considered in the study (the pig gestation site, maternity site, stalls,
the pig fattening area, and quarantine confinement) air samples were collected. In total, 23 air samples
were collected. Air samples (600 L) were collected using the impinger Coriolis® µ air sampler (Bertin
Technologies, Montigny-le-Bretonneux, France) with a flow rate of 300 L of air per minute. Samples
were collected using 10 mL sterile phosphate-buffered saline (PBS) with 0.05% Tritontm X-100 and
were subsequently used for the mycotoxins assay.
Five litter samples (one from each unit) were collected into sterilized bags in the maternity area,
the only area off the swine farm that had litter. Ten feed samples (two from each swine farm) from
different areas of the swine farms were collected into sterilized bags.
5.3. Analytical Methods for the Determination of Mycotoxins and Metabolites
5.3.1. Urine Samples Analysis
Urine samples were stored at 4 ◦C after collection and during transportation to the laboratory.
After aliquotation, 15 mL of these samples were kept frozen at −20 ◦C until analysis in the next
two weeks. After the collection of all samples, dilute-and-shoot sample preparation was used that
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consists only of centrifugation as well as a dilution step of thawed samples in combination with a
HPLC-MS/MS measurement.
In short, samples were centrifuged at 15,000× g for five minutes at 8 ◦C followed by dilution of
10 µL of the supernatant with 90 µL mobile phase at LC-starting conditions, namely a solvent mixture
of acetonitrile, water, and formic acid (95+5+0.1, v/v/v), following the sample preparation from an
earlier published approach [21]. Sample 30 µL of this solution was injected to an Infinity 1260 system
(Agilent, Waldbronn, Germany) on a C18 Pyramid column (100 × 2 mm, 3 µm, Macherey-Nagel,
Düren, Germany) connected to a pre-column filled with the same material (4 × 2 mm, 3 µm). Column
oven temperature was set to 45 ◦C, and the flow rate was 600 µL/min. After chromatographic
separation, the detection was carried out by a QTRAP 6500 triple quadrupole mass spectrometer
(SCIEX, Santa Clara, CA, USA) run by Analyst 1.6.2 software (SCIEX, Santa Clara, CA, USA). Source
parameters were as follows: Temperature was set to 500 ◦C, as well as curtain gas at 40, nebulizer
gas at 45, and heater gas at 55 arbitrary units. Electrospray ionization was used in both polarities
at −4500 V or +5500 V, respectively. Further parameters and characteristics, for example, the used
gradient of the mobile phases or the Multiple Reaction Monitoring (MRM) transitions, can be found
in the original publication of this method application [22]. Analytes of interest are presented in
Table 3. Additionally, the presence of structurally-related compounds and important metabolites was
investigated. Since spot urine samples were used to determine the workers’ exposure to mycotoxins,
it was necessary to perform an adjustment in order to correct for differences in inter-individual
dilution and excretion rates [27]. The determination of urinary creatinine was chosen to perform this
adjustment. Creatinine was determined with a spectrophotometric method based on Jaffe reaction
in automatized equipment (Dimension RXL, Siemens®, Munich, Germany). Results for mycotoxins
urinary concentrations were expressed as µg mycotoxin/g creatinine.
5.3.2. Analyses of the Environmental Samples
Aliquots from feed (0.50 g) and litter (0.25 g) were extracted with 2.0 mL of extraction solvent
(acetonitrile (ACN): water (H2O): acetic acid (AcOH) 79:20:1) on MultiReax shaker (Heidolph,
Germany) for 60 min. Raw extracts after dilution with water (1:1) and centrifugation were injected into
the LC-MS/MS system. Air samples (600 L) were diluted 1:7 (v/v) with extraction solvent and water
mixture (1:1) (Table 7).
Table 7. Limits of Detection (LOD) and Limits of Quantitation (LOQ) for mycotoxins analyzed by
LC-MS/MS in environmental samples.
Mycotoxins LOD (µg/Kg) LOQ (µg/Kg) Calibration Range Recovery (%) ± RSD(n = 3)
Aflatoxin M1 0.06 0.20 0.1–8.1 79 ± 6
Aflatoxin B1 0.06 0.20 0.3–32.1 80 ± 2
Aflatoxin B2 0.06 0.20 0.1–8.0 101 ± 12
Aflatoxin G1 0.10 0.10 0.3–32.4 81 ± 2
Aflatoxin G2 0.12 0.40 0.1–8.0 74 ± 1
Deoxynivalenol 2.70 9.00 3.2–1060 90 ± 2
Deoxynivalenol-3-glucoside 5.41 18.00 5.5–548 85 ± 7
15-Acetyldeoxynivalenol 0.81 2.70 3.3–1100 88 ± 6
3-Acetyldeoxynivalenol 0.81 2.70 3.2–1070 90 ± 1
Deepoxydeoxynivalenol 0.36 1.20 1.7–558 92 ± 5
Nivalenol 4.50 15.00 10.7–1070 83 ± 4
Neosolaniol 0.09 0.30 2.2–740 92 ± 2
Zearalanone 0.45 1.50 3.2–107 85 ± 5
Zearalenone 0.18 0.60 0.5–151 87 ± 3
α-Zearalanol 1.98 6.60 2.0–47.4 83 ± 7
β-Zearalanol 0.93 3.10 1.0–47.2 85 ± 7
β-Zearalenol 1.44 4.80 2.0–47.2 81 ± 1
α-Zearalenol 1.02 3.40 1.0–48.6 89 ± 1
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Table 7. Cont.
Mycotoxins LOD (µg/Kg) LOQ (µg/Kg) Calibration Range Recovery (%) ± RSD(n = 3)
Ochratoxin A 0.06 0.20 2.0–199 103 ± 1
Ochratoxin B 0.09 0.30 1.6–164 99 ± 1
Fumonisin B1 0.51 1.70 8.1–811 64 ± 9
Fumonisin B2 0.36 1.20 8.1–809 70 ± 9
Fumonisin B3 0.45 1.50 2.4–235 66 ± 11
T2 toxin 0.12 0.40 3.2–319 104 ± 4
HT2 toxin 0.27 0.90 3.2–322 98 ± 1
T2 Tetraol 5.41 18.00 7.4–741 87 ± 5
T2 Triol 0.33 1.10 2.2–222 103 ± 6
Monoacetoxyscirpenol 0.12 0.40 1.9–634 93 ± 5
Diacetoxyscirpenol 0.30 1 3.2–322 97 ± 2
Roquefortine C 0.21 0.70 3.5–352 87 ± 4
Griseofulvin 0.09 0.30 2.4–239 94 ± 3
Patulin 1.05 3.50 4.1–405 93 ± 7
Fusarenon-X 4.80 16.00 6.4–319 81 ± 8
Mycophenolic acid 0.21 0.70 2.4–815 101 ± 2
Mevinolin 0.09 0.30 2.4–239 98 ± 1
Sterigmatocystin 0.20 0.60 1.0–101 100 ± 3
Mycotoxins were detected using high-performance liquid chromatography (HPLC) Nexera
(Shimadzu, Tokyo, Japan) with a mass detector API 4000 (Sciex, Foster City, CA, USA). Separation
of mycotoxins was carried out on a chromatographic column Gemini NXC18 (150 × 4.6 mm, 3 µm)
(Phenomenex, Torrance, CA, USA); eluent A was composed of water/acetic acid (99:1, v/v) and
eluent B of methanol /acetic acid (99:1, v/v), both contained 5mM ammonium acetate; eluent flow
rate: 0.75 mL/min, injection volume: 7 µL. The concentrations of mycotoxins were calculated using
external calibration. The Limits of Detection (LOD) and Limits of Quantitation (LOQ) obtained for
each mycotoxin with the analytical method are presented in Table 7. The LOD (signal-to-noise ratio of
3) and LOQ (signal-to-noise ratio of 10), respectively, were estimated (using the Analyst® 1.6.2 software
(Sciex, Foster City, CA, USA), by spiking blank feed extract before extraction at low concentrations.
5.4. Statistical Analysis
Statistical analysis was performed using IBM® SPSS Statistics 20 software (IBM, Armonk, NY,
USA). Descriptive statistics are presented as medians (IQR) and range (minimum and maximum).
Assuming the research (alternative) hypothesis “there is a difference in the distribution of responses to
the outcome variable among the comparison groups” (i.e., that the distribution of responses “depends”
on the group), differences in the proportion of exposures between the control group and workers were
evaluated through the Chi-Square Test of Independence (with continuity correction or the Fisher Exact
Test—in case the conditions of the applied Chi-Square Test of Independence were not satisfied). For this,
the classification of “not exposed” were considered to be the values below the LOD, and “exposed”
considers the values higher than the LOD. The level of p ≤ 0.05 was considered statistically significant.
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